Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, Status and Forecast 2020-2026

Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size, Status and Forecast 2020-2026

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Pertuzumab
1.2.3 Trastuzumab
1.3 Market by Application
1.3.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application: 2020 VS 2026
1.3.2 Combination Therapy
1.3.3 Mono Therapy
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Perspective (2015-2026)
2.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Growth Trends by Regions
2.2.1 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Share by Regions (2015-2020)
2.2.3 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Market Size
3.1.1 Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Revenue (2015-2020)
3.1.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Market Share by Players (2015-2020)
3.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue
3.4 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Concentration Ratio
3.4.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue in 2019
3.5 Key Players Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Area Served
3.6 Key Players Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product Solution and Service
3.7 Date of Enter into Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Breakdown Data by Type (2015-2026)
4.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Size by Type (2015-2020)
4.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Type (2021-2026)
5 Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Breakdown Data by Application (2015-2026)
5.1 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Historic Market Size by Application (2015-2020)
5.2 Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2015-2026)
6.2 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020)
6.3 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020)
6.4 North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2015-2026)
7.2 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020)
7.3 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020)
7.4 Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2015-2026)
8.2 China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020)
8.3 China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020)
8.4 China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2015-2026)
9.2 Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020)
9.3 Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020)
9.4 Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (2015-2026)
10.2 Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020)
10.3 Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020)
10.4 Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.1.4 Roche Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020))
11.1.5 Roche Recent Development
11.2 BOC Sciences
11.2.1 BOC Sciences Company Details
11.2.2 BOC Sciences Business Overview
11.2.3 BOC Sciences Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.2.4 BOC Sciences Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
11.2.5 BOC Sciences Recent Development
11.3 LGM Pharma
11.3.1 LGM Pharma Company Details
11.3.2 LGM Pharma Business Overview
11.3.3 LGM Pharma Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.3.4 LGM Pharma Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
11.3.5 LGM Pharma Recent Development
11.4 Biotechnica Pharma Global
11.4.1 Biotechnica Pharma Global Company Details
11.4.2 Biotechnica Pharma Global Business Overview
11.4.3 Biotechnica Pharma Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.4.4 Biotechnica Pharma Global Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
11.4.5 Biotechnica Pharma Global Recent Development
11.5 KinBio
11.5.1 KinBio Company Details
11.5.2 KinBio Business Overview
11.5.3 KinBio Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.5.4 KinBio Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
11.5.5 KinBio Recent Development
11.6 Merck
11.6.1 Merck Company Details
11.6.2 Merck Business Overview
11.6.3 Merck Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Introduction
11.6.4 Merck Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
11.6.5 Merck Recent Development
12Analyst's Viewpoints/Conclusions
13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 3. Key Players of Pertuzumab
Table 4. Key Players of Trastuzumab
Table 5. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 6. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Regions (US$ Million): 2020 VS 2026
Table 7. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Regions (2015-2020) (US$ Million)
Table 8. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Regions (2015-2020)
Table 9. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 10. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Regions (2021-2026)
Table 11. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Market Trends
Table 12. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Drivers
Table 13. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Challenges
Table 14. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Restraints
Table 15. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue by Players (2015-2020) (US$ Million)
Table 16. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Players (2015-2020)
Table 17. Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer as of 2019)
Table 18. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer by Players Market Concentration Ratio (CR5 and HHI)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Product Solution and Service
Table 21. Mergers & Acquisitions, Expansion Plans
Table 22. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 23. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Type (2015-2020)
Table 24. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue Market Share by Type (2021-2026)
Table 25. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Application (2015-2020)
Table 26. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 27. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size Share by Application (2021-2026)
Table 28. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 29. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2015-2020)
Table 30. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 31. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2015-2020)
Table 32. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (US$ Million) (2015-2020)
Table 33. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Country (2015-2020)
Table 34. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 35. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2015-2020)
Table 36. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 37. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2015-2020)
Table 38. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (US$ Million) (2015-2020)
Table 39. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Country (2015-2020)
Table 40. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 41. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2015-2020)
Table 42. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 43. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2015-2020)
Table 44. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Region (US$ Million) (2015-2020)
Table 45. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Region (2015-2020)
Table 46. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 47. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2015-2020)
Table 48. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 49. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2015-2020)
Table 50. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (US$ Million) (2015-2020)
Table 51. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Country (2015-2020)
Table 52. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Type (2015-2020) (US$ Million)
Table 53. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type (2015-2020)
Table 54. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Application (2015-2020) (US$ Million)
Table 55. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application (2015-2020)
Table 56. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size by Country (US$ Million) (2015-2020)
Table 57. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Country (2015-2020)
Table 58. Roche Company Details
Table 59. Roche Business Overview
Table 60. Roche Product
Table 61. Roche Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 62. Roche Recent Development
Table 63. BOC Sciences Company Details
Table 64. BOC Sciences Business Overview
Table 65. BOC Sciences Product
Table 66. BOC Sciences Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 67. BOC Sciences Recent Development
Table 68. LGM Pharma Company Details
Table 69. LGM Pharma Business Overview
Table 70. LGM Pharma Product
Table 71. LGM Pharma Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 72. LGM Pharma Recent Development
Table 73. Biotechnica Pharma Global Company Details
Table 74. Biotechnica Pharma Global Business Overview
Table 75. Biotechnica Pharma Global Product
Table 76. Biotechnica Pharma Global Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 77. Biotechnica Pharma Global Recent Development
Table 78. KinBio Company Details
Table 79. KinBio Business Overview
Table 80. KinBio Product
Table 81. KinBio Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 82. KinBio Recent Development
Table 83. Merck Company Details
Table 84. Merck Business Overview
Table 85. Merck Product
Table 86. Merck Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020) (US$ Million)
Table 87. Merck Recent Development
Table 88. Research Programs/Design for This Report
Table 89. Key Data Information from Secondary Sources
Table 90. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Type: 2020 VS 2026
Figure 2. Pertuzumab Features
Figure 3. Trastuzumab Features
Figure 4. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Application: 2020 VS 2026
Figure 5. Combination Therapy Case Studies
Figure 6. Mono Therapy Case Studies
Figure 7. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Report Years Considered
Figure 8. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size (US$ Million), YoY Growth 2015-2026
Figure 9. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Regions: 2020 VS 2026
Figure 10. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Regions (2021-2026)
Figure 11. Global Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Share by Players in 2019
Figure 12. Global Top Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer as of 2019
Figure 13. The Top 10 and 5 Players Market Share by Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Revenue in 2019
Figure 14. North America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 15. United States Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 16. Canada Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 17. Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 18. Germany Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 19. France Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 20. U.K. Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 21. Italy Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 22. Russia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 23. Nordic Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 24. Rest of Europe Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 25. Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 26. China Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 27. Japan Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 28. South Korea Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 29. Southeast Asia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 30. India Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 31. Australia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 32. Rest of Asia-Pacific Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 33. Latin America Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 34. Mexico Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 35. Brazil Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 36. Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 37. Turkey Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 38. Saudi Arabia Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 39. UAE Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 40. Rest of Middle East & Africa Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Market Size YoY Growth (2015-2026) & (US$ Million)
Figure 41. Roche Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 42. BOC Sciences Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 43. LGM Pharma Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 44. Biotechnica Pharma Global Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 45. KinBio Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 46. Merck Revenue Growth Rate in Mono-Antibody (mAb) for HER2-Positive Advanced Breast Cancer Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs